Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion type Assertion NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_head.
- NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion description "[However, although CLU and PICALM were confirmed to be associated with AD in this independent sample, they did not improve the ability of a model that included age, sex, and APOE to predict incident AD (improvement in area under the receiver operating characteristic curve from 0.847 to 0.849 in the Rotterdam Study and 0.702 to 0.705 in the Cardiovascular Health Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_provenance.
- NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion evidence source_evidence_literature NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_provenance.
- NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion SIO_000772 20460622 NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_provenance.
- NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion wasDerivedFrom gad-20130706 NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_provenance.
- NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_assertion wasGeneratedBy ECO_0000203 NP77510.RArapxCgolGuYqcNCcTlc0-H5xka6w6PaeFbNLDNn4dE0130_provenance.